The Spectranetics Corporation (SPNC) Shares are Up 6.43%

The Spectranetics Corporation (SPNC) : Traders are bullish on The Spectranetics Corporation (SPNC) as it has outperformed the S&P 500 by a wide margin of 15.19% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 6.5%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 6.43% in the last 1 week, and is up 19.06% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

The stock has recorded a 20-day Moving Average of 12.55% and the 50-Day Moving Average is 20.28%. The Spectranetics Corporation is up 36.35% in the last 3-month period. Year-to-Date the stock performance stands at 53.92%.


The Spectranetics Corporation (NASDAQ:SPNC): stock turned positive on Friday. Though the stock opened at $22.5, the bulls momentum made the stock top out at $24.08 level for the day. The stock recorded a low of $22.19 and closed the trading day at $23.18, in the green by 7.96%. The total traded volume for the day was 1,035,681. The stock had closed at $21.47 in the previous days trading.

The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Companys products are used to treat arterial blockages in the heart and legs and to remove pacemaker and defibrillator cardiac leads. The Company offers excimer laser system known as the CVX-300. Its Vascular Intervention business unit includes a range of peripheral and cardiac laser catheters for ablation of blockages in arteries above and below the knee (peripheral atherectomy) and within coronary arteries (coronary atherectomy); support catheters to facilitate crossing of coronary and peripheral arterial blockages (crossing solutions); and thrombectomy catheters for the removal of thrombus (thrombus management). The Companys Lead Management business unit includes excimer laser sheaths, non-laser sheaths and cardiac lead management accessories.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.